Skip to main content
. 2022 May 23;10(5):1207. doi: 10.3390/biomedicines10051207

Figure 7.

Figure 7

In vitro kinetic release profile of DOX encapsulated in SMLs based on (a) Group A, (b) Group B, and (c) Group C lipid formulations at different conditions of temperature and pH. Triplicate mean fitted to the Weibull kinetic model.